English

CARDIOGENESIS CORP

EDGAR

Quarterly report (10-Q) · filed 1998-11-16

10 filing records in this dataset, filed from 1996-08-13 to 1998-11-16. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.05 million USD

1998-09-30 · USD

Exact inputs and evidence

Revenue: 1053000 USD Source

Operating margin

-697.63%

1998-09-30 · %

Exact inputs and evidence

Operating Income: -7346000 USD Source
Revenue: 1053000 USD Source

Operating cash flow

-6.58 million USD

1998-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -14902000 USD Source
Operating Cash Flow: -8327000 USD Source

Free cash flow

-6.69 million USD

1998-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -14902000 USD Source
Operating Cash Flow: -8327000 USD Source
Capital Expenditure: 628000 USD Source
Capital Expenditure: 516000 USD Source

Cash and cash equivalents: 6.9 million USD 1998-09-30 Source
Exact value

6901000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1998-11-16.

Financial data available through: 1996-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 1996-12-31
Operating income: 3 of 11 periods available· newest 1996-12-31
Net income: 3 of 11 periods available· newest 1996-12-31
Operating cash flow: 3 of 11 periods available· newest 1996-12-31
Capital expenditure: 3 of 11 periods available· newest 1996-12-31
Total assets: 1 of 11 periods available· newest 1996-12-31
Total liabilities: 1 of 11 periods available· newest 1996-12-31
Current assets: 1 of 11 periods available· newest 1996-12-31
current liabilities: No compatible figures in this window
Cash and cash equivalents: 1 of 11 periods available· newest 1996-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 3.5 million

Prior period

−USD 5.3 million

1995-01-01 – 1995-12-31
Current period

−USD 8.8 million

1996-01-01 – 1996-12-31

Exact inputs and evidence

-8800000 − -5299000 = -3501000 USD

-5299000 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
-8800000 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Year-over-year change in Net income: -3501000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8800000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2429 Input fundies:NetIncome: -5299000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2429
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 4.15 million

Prior period

−USD 5.02 million

1995-01-01 – 1995-12-31
Current period

−USD 9.17 million

1996-01-01 – 1996-12-31

Exact inputs and evidence

-9170000 − -5024000 = -4146000 USD

-5024000 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
-9170000 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Year-over-year change in Operating cash flow: -4146000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -9170000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 Input fundies:OperatingCashFlow: -5024000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+858.9%

Prior period

USD 175,000

1995-01-01 – 1995-12-31
Current period

USD 1.68 million

1996-01-01 – 1996-12-31

Exact inputs and evidence

1678000 − 175000 = 1503000 USD

175000 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source
1678000 USD · 1996-01-01 – 1996-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Year-over-year change in Capital expenditure: 1503000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1678000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 Input fundies:CapitalExpenditure: 175000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1996 1996-01-01 – 1996-12-31

Revenue USD 3.96 million 100% of revenue
Cost of revenue USD 2.87 million 72% of revenue
Operating expenses USD 12.18 million 308% of revenue
Operating income −USD 11.09 million −280% of revenue
Tax, interest and other Derived −USD 2.29 million −58% of revenue
Net income −USD 8.8 million −222% of revenue

Cash

Operating cash flow −USD 9.17 million −232% of revenue
Capital expenditure USD 1.68 million 42% of revenue
Free cash flow Derived −USD 10.85 million −274% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Operating loss: operating costs were 380% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	3959000	15045000 Derived	-11086000	-2286000 Derived	-8800000	-10848000 Derived	Source 1996-01-01 – 1996-12-31: 3959000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -11086000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -8800000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -9170000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 1678000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4M 1996

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	3959000	Revenue: 3959000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 3959000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -280% 1996

Net margin -222.3% 1996

Free cash flow margin -274% 1996

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Operating margin	-280%	Operating Income: -11086000 Open source Revenue: 3959000 Open source
19961996-12-31	Net margin	-222.3%	Net Income: -8800000 Open source Revenue: 3959000 Open source
19961996-12-31	Free cash flow margin	-274%	Revenue: 3959000 Open source Operating Cash Flow: -9170000 Open source Capital Expenditure: 1678000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -9.2M 1996

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	-9170000	Operating Cash Flow: -9170000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -10.8M 1996

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	-10848000	Operating Cash Flow: -9170000 Open source Capital Expenditure: 1678000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

4.5% 1996

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Liabilities / assets	4.5%	Total Liabilities: 2902000 Open source Total Assets: 64297000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	Not reported	Current Assets: 60226000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 1.78 million Exact value Exact value: -1784000 USD 1994-01-01 – 1994-12-31: -1784000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDIOGENESIS CORP · 1994-12-31 CARDIOGENESIS CORP (edgar:1013465) Net Income: -1784000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1784000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2429 The citation records this snapshot. The page link may show a newer release later.	−USD 1.74 million Exact value Exact value: -1738000 USD 1994-01-01 – 1994-12-31: -1738000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDIOGENESIS CORP · 1994-12-31 CARDIOGENESIS CORP (edgar:1013465) Operating Cash Flow: -1738000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1738000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 The citation records this snapshot. The page link may show a newer release later.	USD 517,000 Exact value Exact value: 517000 USD 1994-01-01 – 1994-12-31: 517000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDIOGENESIS CORP · 1994-12-31 CARDIOGENESIS CORP (edgar:1013465) Capital Expenditure: 517000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 517000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 The citation records this snapshot. The page link may show a newer release later.	−USD 2.26 million Calculation and evidence -1738000 − 517000 USD Exact free cash flow: -2255000 USD 1994-01-01 – 1994-12-31: -1738000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 517000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDIOGENESIS CORP · 1994-12-31 CARDIOGENESIS CORP (edgar:1013465) Free cash flow: -2255000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1738000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 Input fundies:CapitalExpenditure: 517000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 5.3 million Exact value Exact value: -5299000 USD 1995-01-01 – 1995-12-31: -5299000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDIOGENESIS CORP · 1995-12-31 CARDIOGENESIS CORP (edgar:1013465) Net Income: -5299000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5299000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2429 The citation records this snapshot. The page link may show a newer release later.	−USD 5.02 million Exact value Exact value: -5024000 USD 1995-01-01 – 1995-12-31: -5024000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDIOGENESIS CORP · 1995-12-31 CARDIOGENESIS CORP (edgar:1013465) Operating Cash Flow: -5024000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5024000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 The citation records this snapshot. The page link may show a newer release later.	USD 175,000 Exact value Exact value: 175000 USD 1995-01-01 – 1995-12-31: 175000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDIOGENESIS CORP · 1995-12-31 CARDIOGENESIS CORP (edgar:1013465) Capital Expenditure: 175000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 175000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 The citation records this snapshot. The page link may show a newer release later.	−USD 5.2 million Calculation and evidence -5024000 − 175000 USD Exact free cash flow: -5199000 USD 1995-01-01 – 1995-12-31: -5024000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 175000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDIOGENESIS CORP · 1995-12-31 CARDIOGENESIS CORP (edgar:1013465) Free cash flow: -5199000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5024000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 Input fundies:CapitalExpenditure: 175000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 8.8 million Exact value Exact value: -8800000 USD 1996-01-01 – 1996-12-31: -8800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Net Income: -8800000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8800000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2429 The citation records this snapshot. The page link may show a newer release later.	−USD 9.17 million Exact value Exact value: -9170000 USD 1996-01-01 – 1996-12-31: -9170000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Operating Cash Flow: -9170000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9170000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 The citation records this snapshot. The page link may show a newer release later.	USD 1.68 million Exact value Exact value: 1678000 USD 1996-01-01 – 1996-12-31: 1678000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Capital Expenditure: 1678000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1678000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 The citation records this snapshot. The page link may show a newer release later.	−USD 10.85 million Calculation and evidence -9170000 − 1678000 USD Exact free cash flow: -10848000 USD 1996-01-01 – 1996-12-31: -9170000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 1678000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CARDIOGENESIS CORP · 1996-12-31 CARDIOGENESIS CORP (edgar:1013465) Free cash flow: -10848000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T05:13:03Z Snapshot: 17b4a26b0f66d02a6799b89d93639b3c5a4864a12830c9e4d2d24b32a4f900f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013465?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9170000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2446 Input fundies:CapitalExpenditure: 1678000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013465/0000891618-97-001518.txt#2452 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

10 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0001013465, 1013465, edgar:1013465

CARDIOGENESIS CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1996 1996-01-01 – 1996-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation